Delivery Order SPE2DE24D0013-SPE2D626F76Z3
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $13,709.36 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order, identified as XPRSMVP-10, carries no set-aside designation and represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic solutions. The...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $2,304.20 by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning in the...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,259.80 by the Defense Logistics Agency Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, issued under contract number GXGBSLBXC-10, carries no set-aside designation and represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $2,765.04 on December 16, 2025, under the Defense Logistics Agency Medical Supply Chain contract vehicle. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by December 23, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no small business set-aside designation, reflecting Cepheid's established competitive...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,440 firm fixed-price delivery order (4569923610) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—consistent with Cepheid's core competency in rapid molecular diagnostic testing...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F76Z3Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $1,597.30 by the Defense Logistics Agency Medical Supply Chain on January 5, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, designated 4570403902, carries no set-aside designation and represents procurement of diagnostic testing supplies, test kits, and reagents aligned with Cepheid's core competency in molecular diagnostics. The place of performance is Cepheid's headquarters location in Sunnyvale, California. This delivery order operates within the context of Cepheid's extensive federal contract portfolio supporting the Defense Logistics Agency Medical Supply Chain and other federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency. Cepheid maintains two significant Indefinite Delivery Contracts with the VA—including a $32.8 million contract with VISN 6 extending through September 30, 2030—that establish the framework for ongoing procurement of molecular diagnostic solutions. The company serves as a primary federal supplier of rapid molecular diagnostic testing capabilities for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other conditions through its GeneXpert diagnostic platform and associated test kits and reagents.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/4/26 |